HomeAboutRankingsData Sources
Β© 2026 GeneE
🧬
GeneE
27 sources retrieved Β· Most recent: April 2026 Β· Index updated 14 days ago
β“˜GeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
WNK1
WNK lysine deficient protein kinase 1
Chromosome 12 Β· 12p13.33
NCBI Gene: 65125Ensembl: ENSG00000060237.19HGNC: HGNC:14540UniProt: A5D8Z4
222PubMed Papers
22Diseases
0Drugs
73Pathogenic Variants
FUNCTIONAL ROLE
Highly ConstrainedKinase
RESEARCH IMPACT
TrendingVariant-Rich
CLINICAL
OMIM Disease Gene
DATA QUALITY
βœ“ Experimental GO Evidenceβœ“ Swiss-Prot Reviewed
protein phosphorylationnegative regulation of small GTPase mediated signal transductionprotein kinase activityprotein serine/threonine kinase activityhereditary sensory and autonomic neuropathy type 2pseudohypoaldosteronism type 2Cneurodegenerative diseasegenetic disorder
✦AI Summary

WNK1 (With No lysine [K] kinase 1) is a serine/threonine kinase that serves as a molecular crowding sensor essential for cellular ion homeostasis and volume regulation 1. The protein exists in multiple isoforms, with the kidney-specific WNK1 (KS-WNK1) acting as a dominant-negative regulator of the longer isoform by attenuating its kinase activity 2. WNK1's primary mechanism involves sensing osmotic stress and molecular crowding, leading to rapid formation of membraneless condensates through its intrinsically disordered C-terminus, which amplifies downstream signaling 1. This activation triggers phosphorylation of downstream kinases OSR1 and SPAK, ultimately regulating SLC12 cation-chloride transporters including NCC (sodium-chloride cotransporter) to restore cell volume 13. WNK1 also controls endosomal trafficking through TRIM27-dependent regulation of actin assembly, affecting receptor tyrosine kinase degradation 4. Disease relevance includes familial hyperkalemic hypertension, where WNK1 mutations cause NCC hyperactivation leading to hypertension and hyperkalemia 3. In vascular smooth muscle cells, WNK1 loss promotes inflammatory phenotype switching and aortitis development 5. WNK1 shows altered expression in diabetic nephropathy and may function as a central osmolality sensor in water homeostasis 67.

Sources cited
1
WNK1 functions as a molecular crowding sensor that forms membraneless condensates to coordinate cell volume rescue response
PMID: 36318922
2
Kidney-specific WNK1 isoform acts as dominant-negative regulator and regulates NCC cotransporter
PMID: 35894282
3
WNK1 mutations cause familial hyperkalemic hypertension through NCC hyperactivation
PMID: 39699086
4
WNK1 controls endosomal trafficking through TRIM27-dependent regulation of actin assembly
PMID: 37307465
5
WNK1 deletion in vascular smooth muscle cells causes inflammatory phenotype and aortitis
PMID: 38979610
6
WNK1 expression is altered in diabetic nephropathy affecting potassium secretion
PMID: 31506348
7
WNK1 may function as central osmolality sensor in water homeostasis
PMID: 39435642
Disease Associationsβ“˜22
hereditary sensory and autonomic neuropathy type 2Open Targets
0.77Strong
pseudohypoaldosteronism type 2COpen Targets
0.73Strong
neurodegenerative diseaseOpen Targets
0.56Moderate
genetic disorderOpen Targets
0.52Moderate
uterine fibroidOpen Targets
0.42Moderate
Abnormality of the skeletal systemOpen Targets
0.42Moderate
lung cancerOpen Targets
0.38Weak
hereditary sensory and autonomic neuropathyOpen Targets
0.38Weak
squamous cell lung carcinomaOpen Targets
0.36Weak
Sensorineural hearing impairmentOpen Targets
0.33Weak
urinary tract obstructionOpen Targets
0.30Weak
lung carcinomaOpen Targets
0.29Weak
actinic keratosisOpen Targets
0.28Weak
Abruptio PlacentaeOpen Targets
0.27Weak
rhabdomyolysisOpen Targets
0.26Weak
skin cancerOpen Targets
0.26Weak
skin neoplasmOpen Targets
0.25Weak
obesityOpen Targets
0.25Weak
colorectal cancerOpen Targets
0.25Weak
upper aerodigestive tract neoplasmOpen Targets
0.24Weak
Neuropathy, hereditary sensory and autonomic, 2AUniProt
Pseudohypoaldosteronism 2CUniProt
Pathogenic Variants73
NM_213655.5(WNK1):c.3492dup (p.Asp1165Ter)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A|Inborn genetic diseases|Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜…β˜†β˜†2026β†’ Residue 1165
NM_213655.5(WNK1):c.3226C>T (p.Arg1076Ter)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A|not provided|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A|Hereditary neuropathy or pain disorder
β˜…β˜…β˜†β˜†2025β†’ Residue 1076
NM_213655.5(WNK1):c.3301C>T (p.Gln1101Ter)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A|Inborn genetic diseases|Pseudohypoaldosteronism type 2C;Neuropathy, hereditary sensory and autonomic, type 2A
β˜…β˜…β˜†β˜†2025β†’ Residue 1101
NM_213655.5(WNK1):c.2398C>T (p.Gln800Ter)Pathogenic
not provided|Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜…β˜†β˜†2025β†’ Residue 800
NM_213655.5(WNK1):c.3276dup (p.Ser1093fs)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A|Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜…β˜†β˜†2025β†’ Residue 1093
NM_213655.5(WNK1):c.2920C>T (p.Gln974Ter)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A|Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜…β˜†β˜†2025β†’ Residue 974
NM_018979.4(WNK1):c.1905T>A (p.Asp635Glu)Likely pathogenic
not provided|Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜…β˜†β˜†2024β†’ Residue 635
NM_213655.5(WNK1):c.3526_3529del (p.Thr1176fs)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A|Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C|not provided
β˜…β˜…β˜†β˜†2022β†’ Residue 1176
NM_018979.4(WNK1):c.5365-1G>ALikely pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2026
NM_018979.4(WNK1):c.5510-2A>TLikely pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2025
NM_213655.5(WNK1):c.2826C>A (p.Tyr942Ter)Likely pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A
β˜…β˜†β˜†β˜†2025β†’ Residue 942
NM_213655.5(WNK1):c.3627_3630del (p.Pro1210fs)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2025β†’ Residue 1210
NM_018979.4(WNK1):c.1906C>G (p.Gln636Glu)Likely pathogenic
Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2025β†’ Residue 636
NM_213655.5(WNK1):c.2395-1G>ALikely pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2025
NM_213655.5(WNK1):c.2694_2695del (p.Ser898_Cys899insTer)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2025β†’ Residue 898
NM_018979.4(WNK1):c.6376C>T (p.Arg2126Ter)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2025β†’ Residue 2126
NM_213655.5(WNK1):c.2497_2503del (p.Pro833fs)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2024β†’ Residue 833
NM_213655.5(WNK1):c.2446_2449del (p.Gln816fs)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2024β†’ Residue 816
NM_018979.4(WNK1):c.6426del (p.Asn2143fs)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2024β†’ Residue 2143
NM_018979.4(WNK1):c.4847_4848insTA (p.Leu1617fs)Pathogenic
Neuropathy, hereditary sensory and autonomic, type 2A;Pseudohypoaldosteronism type 2C
β˜…β˜†β˜†β˜†2024β†’ Residue 1617
View on ClinVar β†—
Related Genes
SLC12A3Protein interaction97%RETREG1Protein interaction89%SLC12A2Protein interaction88%SLC12A5Protein interaction83%ITSN1Protein interaction81%SLC12A4Protein interaction80%
Tissue Expression6 tissues
Brain
100%
Heart
93%
Bone Marrow
51%
Lung
38%
Ovary
26%
Liver
23%
Gene Interaction Network
Click a node to explore
WNK1SLC12A3RETREG1SLC12A2SLC12A5ITSN1SLC12A4
PROTEIN STRUCTURE
Preparing viewer…
PDB6FBK Β· 1.74 Γ… Β· X-ray
View on RCSB β†—
Constraintβ“˜
LOEUFβ“˜
0.23Highly Constrained
pLIβ“˜
1.00Intolerant
Observed/Expected LoF0.17 [0.13–0.23]
RankingsWhere WNK1 stands among ~20K protein-coding genes
  • #1,851of 20,598
    Most Researched222 Β· top 10%
  • #1,005of 5,498
    Most Pathogenic Variants73 Β· top quartile
  • #617of 17,882
    Most Constrained (LOEUF)0.23 Β· top 5%
Genes detectedWNK1
Sources retrieved27 papers
Response timeβ€”
πŸ“„ Sources
27β–Ό
1
The single-cell transcriptomic landscape of early human diabetic nephropathy.
PMID: 31506348
Proc Natl Acad Sci U S A Β· 2019
1.00
2
WNK1 in the kidney.
PMID: 35894282
Curr Opin Nephrol Hypertens Β· 2022
0.90
3
The biology of water homeostasis.
PMID: 39435642
Nephrol Dial Transplant Β· 2025
0.80
4
WNK1 mediates M-CSF-induced macropinocytosis to enforce macrophage lineage fidelity.
PMID: 40436823
Nat Commun Β· 2025
0.72
5
Familial Hyperkalemic Hypertension.
PMID: 39699086
Compr Physiol Β· 2024
0.70